rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2001-2-22
|
pubmed:abstractText |
Advances in surgery have reduced the mortality rate after major liver resection, but complications resulting from inadequate postresection hepatic size and function remain. Portal vein embolization (PVE) was proposed to induce hypertrophy of the anticipated liver remnant in order to reduce such complications. The techniques, measurement methods and indications for this treatment remain controversial.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0007-1323
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
88
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
165-75
|
pubmed:dateRevised |
2005-11-16
|
pubmed:meshHeading |
pubmed-meshheading:11167863-Blood Loss, Surgical,
pubmed-meshheading:11167863-Combined Modality Therapy,
pubmed-meshheading:11167863-Embolization, Therapeutic,
pubmed-meshheading:11167863-Humans,
pubmed-meshheading:11167863-Hypertrophy,
pubmed-meshheading:11167863-Liver Diseases,
pubmed-meshheading:11167863-Liver Regeneration,
pubmed-meshheading:11167863-Portal Vein,
pubmed-meshheading:11167863-Postoperative Complications,
pubmed-meshheading:11167863-Survival Analysis,
pubmed-meshheading:11167863-Tomography, X-Ray Computed
|
pubmed:year |
2001
|
pubmed:articleTitle |
Portal vein embolization: rationale, technique and future prospects.
|
pubmed:affiliation |
Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
|
pubmed:publicationType |
Journal Article,
Review
|